Abstract
Heat shock proteins (Hsp) participate in many events related to cancer as molecular chaperones, starting from the very beginning of carcinogenesis. Several etiological factors involve the Hsp family in their mechanisms of action, including oncogenic viruses, hereditary and non hereditary alterations in tumor suppressors or oncoproteins, hypermethylation, radiation and carcinogenic agents. All of them produce changes in the Hsp response with consequences in cell proliferation, differentiation, inflammation, apoptosis, DNA repair, angiogenesis, metastasis, and drug resistance and in the immunological response mounted by the host. In this chapter we will examine the participation of the Hsp response in tumor cell transformation, either by up-regulation or down-regulation of specific Hsp. This can explain the variations in Hsp expression found in pre-neoplastic and neoplastic human tumors in different tissues and organs. These variations have important clinical consequences in cancer progression, and the exploitation of such knowledge may improve anticancer treatment strategies
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adlakha, C.L., Hart, J.P., and Pizzo, S.V., 2001, Kinetics of nonproteolytic incorporation of a protein ligand into thermally activated alfa 2-macroglobulin: evidence for a novel nascent state. J Biol Chem 45:41547–41552
Akira, S., and Takeda, K., 2004, Toll-like receptors signalling. Nat Rev Immunol 4:499–511
Arispe, N., Doh, M., Simakova, O., Kurganov, B., and De Maio, A., 2004, Hsc70 and Hsp70 interact with phosphatidylserine on the surface of PC12 cells resulting in a decrease of viability. FASEB J 18:1636–1645
Asea, A., Kraeft, S.K., Kurt-Jones, E.A., Stevenson, M.A., Chen, L.B., Finberg, R.W., Koo, G.C., and Calderwood, S.K., 2000, Hsp70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6:435–442
Asea, A., Rehli, M., Kabingu, E., Boch, J.A., Bare, O., Auron, P.E., Stevenson, M.A., and Calderwood, S.K., 2002, Novel signal transduction pathway utilized by extracellular Hsp70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277:15028–15034
Atkins, D., Lichtenfels, R., Seliger, B., 2005, Heat shock proteins in renal cell carcinomas. Contrib Nephrol 148:35–56
Barreto, A., Gonzalez, J.M., Kabingu, E., Asea, A., and Fiorentino, S., 2003, Stress-induced release of HSC70 from human tumors. Cell Immunol 222:97–104
Barzilai, A., and Yamamoto, K-I., 2004, DNA damage responses to oxidative stress. DNA repair 3:1109–1115.
Bases, R., 2005, Clonogenicity of human leukemic cells protected from cell-lethal agents by heat shock protein 70. Cell Stress Chaperones 10:37–45
Basu, S., Binder, R.J., Suto, R., Anderson, K.M., and Srivastava, P.K., 2000, Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int Immunol 12:1539–1546.
Basu, S., Binder, R.J., Ramalingham, T., and Srivastava, P.K., 2001, CD91: a receptor for heat shock proteins gp96, hsp90, and calreticulin. Immunity 14:303–313
Becker, T., Hartl, F.L., and Wieland, F., 2002, CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J Cell Biol 158:1277–1285
Becker, B., Multhoff, G., Farkas, B., Wild, P.J., Landthaler, M., Stolz, W., and Vogt, T., 2004, Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases. Exp Dermatol 13:27–32
Bernal, S.D., 1997, Drug Resistance in Oncology, Marcel Dekker, Inc., New York, USA
Berrieman, H.K., Cawkwell, L., O’Kane, S.L., Smith, L., and Lind, M.J., 2006, Hsp27 may allow prediction of the response to single-agent vinorelbine chemotherapy in non-amall cell lung cancer. Oncol Rep 15:283–286
Berwin, B., Hart, J.P., Rice, S., Gass, C., Pizzo, S.V., Post, S.R., and Nicchita, C.V., 2003, Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. EMBO J 22:6127–6136
Berwin, B., Delneste, Y., Lovingood, R.V., Post, S.R., and Pizzo, S.V., 2004, SREC-1, a type F scavenger receptor, is endocytic receptor for calreticulin. J Biol Chem 279:51250–51257
Bienz, M., 2004, Beta catenin: a pivot between cell adhesion and Wnt signaling. Current Biology 15:64–67
Binder, R.J., Harris, M.L., Menoret, A., and Srivastava, P.K., 2000, Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells. J Immunol 165:2582–2587
Binder, R.J., and Srivastava, P.K., 2004, Essential role of CD91 in re-presentation of gp96-chaperoned peptides. Proc Natl Acad Sci USA 101:6128–6133
Blackburn, R.V., Galoforo, S.S., Berns, C.M., Armour, E.P., McEachern, D., Corry, P.M., and Lee, Y.J, 1997, Comparison of tumor growth between hsp25- and hsp27-transfected murine L929 cells in nude mice. Int J Cancer 72:871–877
Broquet, A.H., Thomas, G., Masliah, J., Trugnan, G., and Bachelet, M., 2003, Expression of the molecular chaperone Hsp70 in detergent-resistant microdomains correlates with its membrane delivery and release. J Biol Chem 278:21601–21606
Burdon, R.H., 1986, Heat shock and the heat shock proteins. Biochem J 240:313–324
Butt, E., Immeler, D., Meyer, H.E., Kotlyarov, A., Laass, K., and Gaestel, M., 2001, Heat shock protein 27 is a substrate of cGMP-dependent protein kinase in intact human platelets: phosphorylation-induced actin polymerization caused by HSP27 mutants. J Biol Chem 276:7108–7113
Calderwood, S.K., Khaleque, A., Sawyer, D.B., Ciocca, D.R., 2006, Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31:164–172
Cappello, F., Di Stefano, A., David, S., Rappa, F., Anzalone, R., La Rocca, G., D’Anna, S.E., Magno, F., Donner, C.F., Balbi, B., Zummo, G., 2006, Hsp60 and Hsp10 down-regulation predicts bronchial epithelial carrcinogenesis in smokers with chronic obstructive pulmonary disease. Cancer 107:2417–2424
Castellino, F., Boucher, P.E., Eichelberg, K., Mayhew, M., Rothman, J.E., Houghton, A.N., and Germain, R.N., 2000, Receptor-mediated uptake of antigen/heat shock proteins complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J Exp Med 191:1957–1964
Cavallaro, U., Christofori, G., 2004, Multitasking in tumor progression. Signaling functions of cell adhesion molecules. Ann N Y Acad Sci 1014:58–66
Chauhan, D., Li, G., Auclair, D., Hideshima, T., Richardson, P., Podar, K., Mitsiades, N., Mitsiades, C., Li, C., Kim, RS., Chen, L.B., Wong, W., and Anderson, K.C., 2003, Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays. Blood 101:3603–3614
Chen, X., Tao, Q., Yu, H., Zhang, L., and Cao, X., 2002, Tumor cell membrane-bound heat shock protein 70 elicits antitumor immunity. Immunol Lett 84:81–87
Chiosis, G., Caldas Lopez, E, Solit, D., 2006, Heat shock protein-90 inhibitors: a chronicle from geldamicin to today’s agents. Curr Opin Investig Drugs, 7:534–541
Ciocca, D.R., Puy, L.A., and Lo Castro, G., 1986, Localization of an estrogen-responsive protein in the human cervix during menstrual cycle, pregnancy, and menopause and in abnormal cervical epithelia without atypia. Am J Obstet Gynecol 155:1090–1096
Ciocca, D.R., Puy, L.A., and Fasoli, L.C., 1989, Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patiens with carcinomas of endometrium and cervix. Cancer Res 49:4298–4304.
Ciocca, D.R., Jorge, A.D., Jorge, O., Milutín, C., Hosokawa, R., Díaz Lestren, M., Muzzio, E., Schulkin, S., and Schirbu, R., 1991, Estrogen receptors, progesterone receptors and heat-shock 27KD protein in liver biopsy specimens from patients with hepatitis B virus infection. Hepatology 13:838–844
Ciocca, D.R., Lo Castro, G., Alonio, L.V., Cobo, M.F., Lotfi, H., and Teyssie, A., 1992, Effect of human papillomavirus infection on estrogen receptor and heat shock protein p27 phenotype in human cervix and vagina. Int J Gynecol Path 11:113–121
Ciocca, D.R., Oesterreich, G.C., Chamness, G.C., McGuire, W.L., and Fuqua, S.A.W., 1993, Heat shock protein 27,000 (HSP 27): Biological and clinical implications. J Natl Cancer Inst 85:1558–1570
Ciocca, D.R., and Vargas Roig, L.M., 1997, Heat shock proteins and drug resistance in breast cancer. In Drug Resistance in Oncology (S.D. Bernal, ed.), Marcel Dekker Inc., New York, USA, pp 167–190
Ciocca, D., and Calderwood, S.K., 2005, Heat shock proteins in cancer: diagnostic, prognostic, predictive and treatment implications. Cell Stress & Chaperones 10:86–103
Ciocca, D.R., Vargas-Roig, L.M., Fanelli, M.A., and Nadin, S., 2005, Neoadjuvant chemotherapy in breast cancer: what are we learning from the molecular studies? Trends in Cancer Res 1:77–91.
Ciocca, D.R., Gago, F.E., Fanelli, M.A., and Calderwood S.K., 2006, Co-expression of steroid hormone receptors (estrogen receptor α and/or progesterone receptors) and Her-2/neu: clinical implications. J Steroid Biochem Mol Biol 102:32–
Ciupitu, A.M., Petersson, M., Kono, K., Charo, J., and Kiessling, R., 2002, Immunization with heat shock protein 70 from methylcholanthrene-induced sarcomas induces tumor protection correlating with in vitro T cell responses. Canc Immunol Immunother 51:163–170
Czarnecka, A.M., Campanella, C., Zummo, G., Cappello, F., 2006, Mitochondrial chaperones in cancer: from molecular biology to clinical diagnostics. Cancer Biol Ther 5:714–720
Deichmann, M., Polychronidis, M., Benner, A., Kleist, C., Thome, M., Kahle, B., and Helmke, B.M., 2004, Expression of the heat shock cognate HSP73 correlates with tumor thickness of primary melanomas and is enhanced in melanoma metastases. Int J Oncol 25:259–268
Delneste, Y., Magistrelli, G., Gauchat, J., Haeuw, J., Aubry, J., Nakamura, K., Kawakami-Honda, N., Goetsch, L., Sawamura, T., Bonnefoy, J., and Jeannin, P., 2002, Involmement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17:353–362
Dong, D., Ko, B., Baumeister, P., Swenson, S., Costa, F., Markland, F., Stiles, C., Patterson, J.B., Bates, S.E., and Lee, A.S., 2005, Vascular targeting and antiangiogenesis agents induce drug resistance effector GRP78 within the tumor microenvironment. Cancer Res 65:5785–5791
Doody, A.D., Kovalchin, J.T., Mihalyo, M.A., Hagymasi, A.T., Drake, C.G., and Adler, A.J., 2004, Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function. J Immunol 172:6087–6092
Doppler, H., Storz, P., Li, J., Comb, M.J., and Toker, A., 2005, A phosphorylation state-specific antibody recognizes Hsp27, a novel substrate of protein kinase D. J Biol Chem 280:15013–15019
Erkizan, O., Kirkali, G., Yorukoglu, K, and Kirkali, Z., 2004, Significance of heat shock protein-27 expression in patients with renal cell carcinoma. Urology 64:474–478
Eustace, B.K., and Jay, D.G., 2004, Extracellular roles for molecular chaperone, hsp90. Cell Cycle 3:1098–1100
Facciponte, J.G., MacDonald, I.J., Wang X.Y., Kim, H., Manjili, M.H, and Subjeck J.R., 2005, Heat shock proteins and scavenger receptors: role in adaptive immune responses. Immunol Invest 34:325–342
Fernandez, P.M., Tabbara, S.O., Jacobs, L.K., Manning, F.C.R., Tsangaris, T.N., Schwartz, A.M., Kennedy, K.A., and Patierno, S.R., 2000, Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions. Breast Cancer Res Treat 59:15–26
Finlay, C., Hinds, P., Frey, A.B., and Levine, A.J., 1988, Mutations which activate p53 transformation with ras produce an altered p53 protein that preferentially binds to a heat shock protein hsc70. Mol Cell Biol 8:531–539
Gatstpar, R., Gross, C., Rossbacher, L., Ellwart, J., Riegger, J., and Multhoff, G., 2004, The cell surface-localized heat shock protein 70 epitope TDK induces migration and cytolitic activity selectively in human NK cells. J Immunol 172:972–98
Germanov, E., Berman, J.N., Guernsey, D.L., 2006, Current and future approaches for the therapeutic targeting of metastasis. Int J Mol Med. 18:1025–1036
Gross, C., Schmidt-Wolf, I.G., Nagaraj, S., Gatspar, R., Ellwart, J., Kunz-Schughart, L.A., and Multhoff, G., 2003, Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells. Cell Stress & Chaperones 8:348–360
Habich, C., Baumgart, K., Kolb, H., and Burkart, V., 2002, The receptor for heat shock protein 60 on macrophages is saturable specific, and distinct from receptors for other heat shock proteins. J Immunol 168:568–576
Hsu, P.L., and Hsu, S.M., 1998, Abundance of heat shock proteins (hsp89, hsp60, and hsp27) in malignant cells of Hodgkin disease. Cancer Res 58:5507–5513
Irah, Y., Takamura, A., Leo, N., Manu,, Y., Sato, H., Surnaga, N., 2001, Homophilic complex formation of MT1 MMP facilitates pro MMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 20:4782–4793
Janetzki, S., Palla, D., Rosenhauer, V., Lochs, H., Lewis, J.J., and Srivastava, P.K., 2000, Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study. Int J Cancer 88:232–38
Jorge, O., Cuello Carrión, F.D., Jorge, A., and Ciocca, D.R., 2003, Helicobacter Pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa. Rev Esp Enferm Dig (Madrid) 95:97–104
Kai, M., Nakatsura, T., Egami, H., Senju, S., Nishimura, Y., and Ogawa, M., 2003, Heat shock protein 105 is overexpressed in a variety of human tumors. Oncol Rep 10:1777–1782
Katoh, M., Koninkcx, J., and Schumacher, U., 2000, Heat shock protein expression in human tumors grown in severe combined immunodeficient mice. Cancer Lett 161:113–120
Kelly, J.M., Darcy, P.K., Markby, J.L., Godfrey, D.I., Takeda, K., Yagita, H., and Smyth, M.J., 2002, Induction of tumor-specific T cell memory by NK cells-mediated tumor rejection. Nat Immunol 3:83–90
Kenny, M.K., Mendez, F., Sandigursky, M., Kurekattil, R.P., Goldman, J.D., Franklin, W.A., and Bases, R., 2001, Heat shock protein 70 binds to human apurinic/apyrimidic endonuclease and stimulates endonuclease activity at abasic sites. J Biol Chem 276:9532–9536
Khaleque, A., Bharti, A., Sawyer, D., Gong, J., Benjamin, I.J., Stevenson, M.A., and Calderwood, S.K., 2005, Induction of heat shock proteins by heregulin beta 1 leads to protection from apoptosis and anchorage-independent growth. Oncogene 24:6564–6573
Ki Deok, S., Mi-Young, L., Dae-Seop, S., Sangku, L., Kwang-Hee, S., Sukhoon, K., Young-Ki, P., Byoung-Mog, K., and Dong C., 2005, Blocking tumor cell migration and invasion with Biphenyl Isoxazole derivative kribb3, a synthetic molecule that inhibits hsp27 phosphoryltaion. J Biol Chem 280:41439–41448
Kuppner, M.C., Gastpar, R., Gelwer, S., Noessner, E., Ochmann, O., Scharner, A., and Issels, R.D., 2001, The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocytes precursors. Eur J Immunol 31:1602–1609
Landry, J., Lambert, H., Zhou, M., Lavoie, J.N., Hickey, E., Weber, L.A., and Anderson, C.W., 1992, Human HSP27 is phosphorylated at serines 78 and 82 by heat shock and mitogen-activated kinases that recognize the same amino acid motif as S6 kinase II. J Biol Chem 267:794–803
Lee, J.H., Sun, D., Cho, K.J., Kim, M.S., Hong, M.H., Kim, I.K., Lee, J.S., and Lee, J.H., 2006, Overexpression of human 27 kDa heat shock protein in laryngeal cancer cells confers chemorresistance associated with cell growth delay. J Cancer Res Clin Oncol (E pub ahead of print)
Lehman, T.A., Bennet, W.P., Matcalf, R.A., Welsh, J.A., Ecker, J., Modali, R.V., Ullrich, S., Romano, J.W., Appella, E., Testa, J.R., Gerwin, B.I., and Harris, C.C., 1991, p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 51:4090–4096
Li, J., and Lee, A.S., 2006, Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med 6:45–54
Lim, S.O., Park, S.G., Yoo, J.H., Park, Y.M., Kim, H.J., Jang, K.T., Cho, J.W., Yoo, B.C., Jung, G.H., Park, C.K., 2005, Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules. World J Gastroenterol 11:2072–2079
Ludwig, S., Engel, K., Hoffmeyer, A., Sithanandam, G., NeufeldB., Palm, D., Garstel, M., and Rapp, U.R., 1996, 3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Mol Cell Biol 16:6687–6697
Maizels, E.T., Peters, C.A., Kline, M., Cutler, R.E., Shanmugan, M., and Hunzicker-Dunn, M., 1998, Heat-shock protein-25/27 phosphorylation by the delta isoform of protein kinase C. Biochem J 332:703–712
Maloney, A., and Workman, P., 2002, Hsp90 as a new therapeutic target for cancer therapy: the story unfolds. Expert Opin Biol Ther 2:3–24
Massa, C., Melani, C., and Colombo, M.P., 2005, Chaperon and adjuvant activity of hsp70: different natural requirement for cross-priming of chaperoned and bystander antigens. Cancer Res 65:7942–7949
Michaelsson, J., Teixeira, D.M., Anchour, A., Lanier, L.L., Karre, K., and Soderstrom, K., 2002, A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J Exp Med 196:1403–1414
Mizzen, L., 1998, Immune responses to stress proteins: applications to infectious disease and cancer. Biotherapy 10:173–89
Monick, M.M., Carter, A.B., Robeff, P.K., Flaherty, D.M., Peterson, M.W., and Hunninghake, G.W., 2001, Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of β-catenin. J Immunol 166:4713–4720
Multhoff, G., Pfister, K., Botzler, C., Jordan, A., Scholz, R., Schmetzer, H., Burgstahler, R., and Hiddemann, W., 2000, Adoptive transfer of human natural killer cells in mice with severe combined immunodeficiency inhibits growth of Hsp70-expressing tumors. Int J Cancer 88:791–797
Multhoff, G., 2006, Heat shock proteins and immunity. Handb Exp Pharmacol 172:279:304
Nadin, S.B., Vargas-Roig, L.M., Cuello-Carrión, F.D., and Ciocca, D.R., 2003, Deoxyribonucleic acid damage induced by doxorubicin in peripheral blood mononuclear cells: possible roles for the stress response and the deoxyribonucleic acid repair process. Cell Stress & Chaperones 8:361–372
Nadin, S.B., Vargas-Roig, L.M., Fanelli, M., Drago, G., Ibarra, J., and Ciocca, D.R., 2006, Hsp27 and Hsp70 may contribute with the DNA repair function of hMLH1 and hMSH2 in peripheral blood lymphocytes from normal subjects and cancer patients. 5th International Workshop on the Molecular Biology of Stress Responses, Concepción, Chile, pp 83
Neckers, L., and Ivy, S.P., 2003, Heat shock protein 90, Curr Opin Oncol 15:419–424
Nihei, T., Takahashi, S., Sagae, S., Sato, N., and Kikuchi, K., 1993, Protein interaction of retinoblastoma gene product pRb110 with Mr 73,000 heat shock cognate protein. Cancer Res 53:1702–1705
Niu, P., Liu, L., Gong, Z., Tan, H., Wang, F., Yuan, J., Feng, Y., Wei, Q., Tanguay, R.M., and Wu, T., 2006, Overexpressed heat shock protein 70 protects cells against DNA damage caused by ultraviolet C in a dose-dependent manner. Cell Stress Chaperones 11:162–169
Ohashi, K., Burkart, V., Flohe, S., and Kolb, H., 2000, Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164:558
Ollins, G.J., Nikitakis, N., Norris, K., Herbert, C., Siavash, H., and Sauk, JJ., 2002, The production of the endostatin precursor collagen XVIII in head and neck carcinomas is modulated by CBP2/Hsp47. Anticancer Res 22:1977–1982
Osada, M., Imaoka, S., and Funae, Y., 2004, Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1 alpha protein. FEBS lett 575:59–63
Panjwani, N.N., Popova, L., and Srivastava, P.K., 2002, Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. J Immunol 168:2997–3003
Price, J.T., Quinn, J.M.W., Sims, N.A., Viesseux, J., Waldeck, K., Docherty, S.E., Myers, D., Nakamura, A., Waltham, M.C., Gillespie, M.T., and Thompson, E.W., 2005, The heat shock protein 90 inhibitor, 17-allylamino-17demethoxygeldamicin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line. Cancer Res 65:4929-4938
Puy, L.A., Lo Castro, G., Olcese, J.E., Lotfi, H.O., Brandi, H.R., and Ciocca, D.R., 1989, Analysis of a 24-kilodalton (KD) protein in the human uterine cervix during abnormal growth. Cancer 64:1067–1073
Quinlan, R., 2002, Cytoskeletal competence requires protein chaperones. In Progress in Molecular and Subcellular Biology, Vol 28 (A.-P. Arrigo and W.E.G. Müller, eds.), Springer-Verlag, Berlin, Germany, pp 219–233
Ralhan, R., and Kaur, J., 1995, Differential expression of Mr 70,000 heat shock protein in normal, premalignant, and malignant human uterine cervix. Clin Cancer Res 1:1217–1222
Roosi, A., Ciafre, S., Balsamo, M., Pierimarchi, P., and Santoro, M.G., 2006, Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer. Cancer Res 66:7678–85
Sanderson, S., Valenti, M., Gowan, S., Patterson, L., Ahmad, Z., Workman, P., and Eccles, S., 2006, Benzoquinone ansamycin heat shock protein90 inhibitors modulate multiple functions required for tumor angiogenesis. Mol Cancer Ther 5:522–532
Schild, H., Arnold-Schild, D., Lammert, E., and Rammensee, H.G., 1999, Stress proteins and immunity-mediated by cytotoxic T lymphocytes. Curr Opin Immunol 11:109–113
Shin, B.K., Wang, H., Yim, A.M., Le Naour, F., Brichory, F., Jang, J.H., Zhao, R., Puravs, E., Tra, J., Michael, C.W., Misek, D.E., and Hanash, S.M., 2003, Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone functions. J Biol Chem 278:7607–7616
Singh-Jasuja, H., Toes, R.E., Spee, P., Munz, C., Hilf, N., Schoenberger, S.P., Ricciardi-Castagnoli, P., Neefjes, J., Rammensee, H.G., and Arnold-Schild, D., 2000, Cross-presentation of glycoprotein 96 associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J Exp Med 191:1965–1974
Soga, S., Shiotsu, Y, Akinaga, S., and Sharma, S.V., 2003, Development of radicicol analogues. Curr Cancer Drug Targets 3:359–369
Sondermann, H., Becker, T., Mayhew, M., Wieland, F., and Hartl, F.U., 2000, Characterization of a receptor for heat shock protein 70 on macrophages and monocytes. Biol Chem 381:1165–1174
Srivastava, P.K., DeLeo, A.B., and Old, L.J., 1986, Tumor rejection antigens of chemically induced sarcomas in inbred mice. Proc Natl Acad Sci USA 83:3407–3411
Strbo, N., Oizumi, S., Sotosek-Tokmadzic, V., and Podack, E.R., 2003, Perforin is required for innate and adaptive immunity induced by heat shock protein gp96. Immunity 18:381–390
Taira, T., Sawai, M., Ikeda, K., Tamai, K., Iguchi-Ariga, S.M., Ariga, H., 1999, Cell cycle-dependent switch of up-and down-regulation of human hsp70 gene expresión by interaction between c-myc and cbf/nf-y. J Biol Chem 274:24270–24279
Todryk, S.M., Melcher, A.A., Dalgleish, A.G., and Vile, R.G., 2000, Heat shock proteins refine the danger theory. Immunology 99:334–337
Tragosz, A., Pierzchalski, P., Krawiec, A., Szczyrk, U., Brzozowski, T., Konturek, S.J., and Pawlik, W.W., 2006, Helicobacter pylori inhibits expression of heat shock protein 70 (HSP70) in human epithelial cell line. Importance of Cag A protein. J Physiol Pharmacol 57:265–278
Triantafilou, M., and Triantafilou, K., 2004, Heat shock protein 70 and heat shock protein 90 associate with Toll-like receptor 4 in response to lipopolysaccharide. Biochem Soc Trans 32:636–639
Udono, H., and Srivastava, P.K., 1993, Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 178:1391–1396
Udono, H., and Srivastava, P.K., 1994, Comparision of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90 and hsp70. J Immunol 152:5398–5403
Ulmann, R., Morbini, P., Halbwedl, I., Bongiovanni, M., Gogg-Kammerer, M., Papotti, M., Gabor, S., Renner, H., and Popper, H.H., 2004, Protein expression profiles in adenocarcinomas and squamous cell carcinomas of the lung generated using tissue microarrays. J Pathol 203:798–807
Vabulas, R.M., Wagner, H., and Schild, H., 2002, Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol 270:169
Vargas Roig, L.M., Fanelli, M.A., Lopez, L.A., Gago, F.E., Tello, O., Aznar, J.C., and Ciocca, D.R., 1997, Heat shock proteins and cell proliferation in human breast cancer biopsy samples. Cancer Detect Prevent 21:441–451
Walsh, R.C., Koukoulas, I, Garnham, A., Moseley, P.L., Hargreaves, M, and Febraio, M.A., 2001, Exercise increases serum Hsp72 in humans. Cell Stress & Chaperones 6:386–393.
Wang Y., Kelly, C.G., Singh, M., McGowan, E.G., Carrara, A.S., Bergmeier, L.A., and Lehner, T., 2002, Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J Immunol 169:2422–2429
Workman, P., 2004, Combinatorial attack on multistep oncogenesis by inhibiting the hsp90 molecular chaperone. Cancer Lett 206:149–157
Xian Ma, Y., Fan, S., Xion, J., Yan, R.Q., Meng, Q., Gao, M., Goldberg, M., Fuqua, S.A.W., Pestell, R.G., and Rosen, E.M., 2003, Role of BRCA1 in heat shock response. Oncogene 22:10–27
Xiao, C., Chen, S., Li, J., Hai, T., Lu, Q., Sun, E., Wang, W., Tanguay, R.M., and Wu, T., 2002, Association of Hsp70 and genotoxic damage in lymphocytes of workers exposed to coke-oven emission. Cell Stress Chaperones 7:396–402
Xu, L., Chen, S., and Bergan R.C., 2006, MAPKAPK2 and hsp27 are downstream effectors of p38 MAP kinase mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer, Oncogene 25:2987–2998
Yang, L., and Carbone D.P., 2004, Tumor-host immune interactions and dendritic cell dysfunction. Adv Cancer Res 92:13–27
Yang, Q., Liu, S., Tian, Y., Hasan, C., Kersey, D., Salwen, H.R., Chlenski, A., Perlman, E.J., and Cohn, S.L., 2004, Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma. Cancer Res 64:4531–4538
Yano, M., Naito, Z., Yokoyama, M., Shiraki, Y., Ishiwata, T., Inokuchi, M., and Asano, G., 1999, Expression of hsp90 and cyclin D1 in human breast cancer. Cancer Lett 137:45–51.
Yeo, M., Park, H.K., Kim, D.K., Cho, S.W., Kim, Y.S., Cho, S.Y., Paik, Y.K., Hahm, K.B., 2004, Restoration of heat shock protein 70 suppresses gastric mucosal inducible nitric oxide synthase expression induced by Helicobater pylori. Proteomics 4:3335–3342
Zanin-Zhorov, A., Cahalon, L., Tal, G., Margalit, R., Lider, O., and Cohen, I.R., 2006, Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest 116:2022–2032
Zhang, D., Tai, L.K., Wong, L.L., Chiu, L.L., Sethi, S.K., Koay, E.S., 2005, Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in Her-2/neu-positive breast cancer. Mol Cell Proteomics 4:1686–1696
Zou, W., 2005, Immunosuppressive networks in the tumor environment and their therapeutic relevance. Nat Rev Cancer 5:263–274
Zsebik, B., Citri, A., Isola, J., Yarden, Y., Szollosi, J., and Vereb, G., 2006, Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1. Immunol Lett 104:146–155.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Ciocca, D.R., Fanelli, M.A., Cuello-Carrión, F.D., Calderwood, S.K. (2007). Implications of Heat Shock Proteins in Carcinogenesis and Cancer Progression. In: Calderwood, S.K., Sherman, M.Y., Ciocca, D.R. (eds) Heat Shock Proteins in Cancer. Heat Shock Proteins, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6401-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4020-6401-2_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-6400-5
Online ISBN: 978-1-4020-6401-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)